Full-Time

Associate Business Development Executive

Commercial

Posted on 8/28/2025

Deadline 10/27/25
PCI Pharma Services

PCI Pharma Services

1-10 employees

Pharmaceutical packaging and contract services

Compensation Overview

$68.5k - $77k/yr

+ Annual Performance Bonus

Rockford, IL, USA + 1 more

More locations: Philadelphia, PA, USA

In Person

Ability to travel greater than 40% of the time.

Category
Business & Strategy (1)
Required Skills
Salesforce
Requirements
  • Minimum of 1-5 years in CDMO Project Management, Cost Estimation/Cost Modeling, Operations, or Engineering for Pharmaceutical Packaging/Manufacturing
  • Strong project management skills and the ability to juggle multiple client needs simultaneously
  • Executive presence and strong interpersonal communication skills, both written and verbal
  • Confidence to work independently, influence stakeholders, and handle challenging conversations
  • Highly organized, detail-oriented, and motivated to exceed client expectations
  • Intermediate to advanced proficiency in Microsoft Office (Word, Excel, PowerPoint) and Smartsheets
  • Proficiency in CRM systems (Salesforce preferred)
  • Ability to travel >40% of the time
Responsibilities
  • Serve as a liaison between Global Accounts, the Global Account Director and internal teams to ensure timely responses to issues and support effective account management for top-tier pharmaceutical and biotech clients
  • Lead or contribute to the identification, qualification, and closure of new revenue opportunities, including upselling and cross-selling within the global client base
  • Participate in quarterly business reviews, collaborating across functions to prepare content, drive internal engagement, and deliver a polished client-facing experience
  • Independently manage incoming quote requests by gathering requirements, submitting estimate/design requests through Salesforce, partnering with internal engineering and estimating teams, and delivering accurate, client-ready proposals
  • Provide critical input on annual and quarterly sales planning, forecasting, and territory management. Maintain and track accurate opportunity pipelines in Salesforce
  • Work closely with operations, project management, finance, legal, and other departments to ensure optimal service delivery, timeline adherence, and client satisfaction
  • Lead PCI the planning and execution of site visits for clients including internal scheduling, content preparation, and on-site hosting to ensure a world-class client experience
  • Stay abreast of industry trends, competitor activity, and client developments to proactively identify opportunities for innovation and strategic alignment
  • Represent PCI at trade shows, conferences, and site visits, contributing to brand visibility and lead generation
  • Proactively support contract processes including CDAs, MSAs, and other legal documentation, liaising between PCI and client legal teams
  • Independent ownership of small/ mid-sized customers

PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$4B

Headquarters

Burlington, Canada

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • GLP-1 surge drives demand for PCI's prefilled syringes and autoinjectors.
  • Oncology-CNS pipelines favor PCI's patient-centric drug-device combinations.
  • Bain Capital's $10B valuation fuels $1B capacity expansions through 2028.

What critics are saying

  • San Diego isolator line delays to H1 2028 cede contracts to Lonza.
  • Novo Nordisk's Catalent acquisition slashes external CDMO fill-finish availability.
  • PE backers force divestitures if biotech funding dries post-2025.

What makes PCI Pharma Services unique

  • PCI integrates sterile fill-finish with drug-device assembly for end-to-end injectables.
  • Ajinomoto Althea acquisition adds rare US high-potent ADC sterile filling expertise.
  • AVI systems inspect 75 million vials annually, scaling quality without bottlenecks.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Company News

BioProcess International
Aug 15th, 2025
Building a better facility: BPI tours PCI manufacturing plant in Bedford

On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.

Montgomery County
Jul 24th, 2025
PCI Pharma Services Valued at $10B

PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.

JD Supra
Jul 16th, 2025
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital and Kohlberg Invest in PCI Pharma

Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.

FinSMEs
Jul 15th, 2025
PCI Pharma Services Receives Investment from Mubadala, Bain Capital, and Kohlberg

PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.

MarketScreener
Jul 14th, 2025
PCI Pharma Services receives new funding

PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.

INACTIVE